Our Director at Lucid Health Consulting, George Papadopoulos, authored the ISPOR, Research RoundUp in the November-December 2020 Edition of the Value & Outcomes Spotlight.
The articles in this session of Research Roundup look at precision medicine. Precision medicine delivers targeted treatments to specific groups of patients based on individual characteristics. It has held promise for many years as a tailored approach to both disease prevention and treatment that considers the differences in people’s genetic makeup. Genomic sequencing underpins the value of precision medicine in being able to better predict, prevent, diagnose, and treat diseases. Whilst there is an abundance of literature on precision medicine, we have tried to identify recent research that encapsulates these characteristics.
ISPOR | November/December 2020 Value & Outcomes Spotlight, RESEARCH ROUNDUP
Section Editor: George Papadopoulos.
Read the full article: Research RoundUp – Challenges in Precision Medicine: Aiming to Align Data, Value, and Costs
About the author:
George Papadopoulos, Partner and Director at Lucid Health Consulting. George is a Health Economist, Pricing and Reimbursement and Strategic Market Access Expert with over 25 years in the healthcare industry in both Australia and USA. An experienced key speaker and commentator, his current leadership roles include chairman of ARCS Australia and Lecturer at UNSW, Pharmaceutical Medicine.
Recent Comments